Draft versus finished sequence data for DNA and protein diagnostic signature development

Nucleic Acids Research

Volumn 33, Issue 18, 2005, Pages 5838-5850

  Gardner, Shea N ^a   Lam, Marisa W ^a   Smith, Jason R ^a   Torres, Clinton L ^a   Slezak, Tom R ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANALYTICAL ERROR; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DNA SEQUENCE; GENE NUMBER; GENE SEQUENCE; GENE TARGETING; GENETIC CONSERVATION; MARBURG VIRUS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN ANALYSIS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SIMULATION; SMALLPOX VIRUS; BACTERIAL GENOME; BIOLOGY; CHEMISTRY; COMPUTER PROGRAM; EVALUATION; GENETICS; GENOMICS; ISOLATION AND PURIFICATION; METHODOLOGY; VIRUS GENOME;

LAKE VICTORIA MARBURGVIRUS; VARIOLA VIRUS;

VIRUS PROTEIN;

COMPUTATIONAL BIOLOGY; GENOME, BACTERIAL; GENOME, VIRAL; GENOMICS; MARBURGVIRUS; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, PROTEIN; SOFTWARE; VARIOLA VIRUS; VIRAL PROTEINS;

EID: 27244444052     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gki896     Document Type: Article

References (16)

1. Branscomb,E. and Predki,P. (2002) On the high value of low standards. J. Bacteriol., 184, 6406-6409.
2. Gordon,D., Desmarais,C. and Green,P. (2001) Automated finishing with autofinish. Genome Res., 11, 614-625.
3. Fraser,C.M., Eisen,J.A., Nelson,K.E., Paulsen,I.T. and Salzberg,S.L. (2002) The value of complete microbial genome sequencing (you get what you pay for). J. Bacteriol., 184, 6403-6405.
4. Bouck,J., Miller,W., Gorrell,J.H., Muzny,D. and Gibbs,R.A. (1998) Analysis of the quality and utility of random shotgun sequencing at low redundancies. Genome Res., 8, 1074-1084.
5. Gardner,S.N., Lam,M.W., Mulakken,N.J., Torres,C.L., Smith,J.R. and Slezak,T.R. (2004) Sequencing needs for viral diagnostics. J. Clin. Microbiol., 42, 5472-5476.
6. Gardner,S.N., Kuczmarksi,T.A., Zhou,C.E., Lam,M.W. and Slezak,T.R. (2005) A System to Assess Genome Sequencing Needs for Viral Protein Diagnostics and Therapeutics. J. Clin. Microbiol., 43, 1807-1817.
7. Slezak,T., Kuczmarski,T., Ott,L., Torres,C., Medeiros,D., Smith,J., Truitt,B., Mulakken,N., Lam,M., Vitalis,E. et al. (2003) Comparative genomics tools applied to bioterrorism defence. Brief. Bioinform, 4, 133-149.
8. Fitch,J.P., Gardner,S.N., Kuczmarski,T.A., Kurtz,S., Myers,R., Ott,L.L., Slezak,T.R., Vitalis,E.A., Zemla,A.T. and McCready,P.M. (2002) Rapid development of nucleic acid diagnostics. Proc. IEEE, 90, 1708-1721.
9. Fitch,J.P., Chromy,B.A., Forde,C.E., Garcia,E., Gardner,S.N., Gu,P., Kuczmarksi,T.A., Melius,C., McCutchen-Maloney,S.L., Milanovich,F.M. et al. (2002) Biosignatures of pathogen and host. Proceedings of the IEEE Workshop on Genomic Signal Processing and Statistics (GENSIPS), Raleigh, NC,.
10. Gardner,S.N., Kuczmarski,T.A., Vitalis,E.A. and Slezak,T.R. (2003) Limitations of TaqMan® PCR for detecting divergent viral pathogens illustrated by hepatitis A, B, C, and E viruses and human immunodeficiency virus. J. Clin. Microbiol., 41, 2417-2427.
11. Benson,D.A., Karsch-Mizrachi,I., Lipman,D.J., Ostell,J., Rapp,B.A. and Wheeler,D.L. (2000) GenBank. Nucleic Acids Res., 28, 15-18.
12. Matthews,T., Salgo,M., Greenberg,M., Chung,J., DeMasi,R. and Bolognesi,D. (2004) Enfuvirtide: The first therapy to inhibit the entry of HIV-1 into host CD 4 lymphocytes. Nature Rev. Drug Discov., 3, 215-225.
13. Okkels,L.M., Brock,I., Follmann,F., Agger,E.M., Arend,S.M., Ottenhoff,T.H., Oftung,F., Rosenkrands,I. and Andersen,P. (2003) PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infect. Immun., 71, 6116-6123.
14. McGaughey,G., Barbato,G., Bianchi,E., Freidinger,R., Garsky,V., Hurni,W., Joyce,J., Liang,X., Miller,M., Pessi,A. et al. (2004) Progress towards the development of a HIV-1 gp41-directed vaccine. Curr. HIV Res., 2, 193-204.
15. Choy,W., Lin,S., Chan,P., Tam,J., Lo,Y., Chu,I., Tsai,S., Zhong,M., Fung,K., Waye,M. et al. (2004) Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development. Clin. Chem., 50, 1036-1042.
16. Giegerich,R., Kurtz,S. and Stoye,J. (2003) Efficient implementation of lazy suffix trees. Software-Practice and Experience, 33, 1035-1049.